BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 21239732)

  • 1. Shape-specific polymeric nanomedicine: emerging opportunities and challenges.
    Tao L; Hu W; Liu Y; Huang G; Sumer BD; Gao J
    Exp Biol Med (Maywood); 2011 Jan; 236(1):20-9. PubMed ID: 21239732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
    Winter PM; Cai K; Caruthers SD; Wickline SA; Lanza GM
    Expert Rev Med Devices; 2007 Mar; 4(2):137-45. PubMed ID: 17359221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling particle shape-dependent dynamics in nanomedicine.
    Shah S; Liu Y; Hu W; Gao J
    J Nanosci Nanotechnol; 2011 Feb; 11(2):919-28. PubMed ID: 21399713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
    Gaumet M; Vargas A; Gurny R; Delie F
    Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrohydrodynamic atomization for biodegradable polymeric particle production.
    Xie J; Lim LK; Phua Y; Hua J; Wang CH
    J Colloid Interface Sci; 2006 Oct; 302(1):103-12. PubMed ID: 16842810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward therapeutic delivery with layer-by-layer engineered particles.
    Yan Y; Such GK; Johnston AP; Lomas H; Caruso F
    ACS Nano; 2011 Jun; 5(6):4252-7. PubMed ID: 21612259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery.
    Talelli M; Rijcken CJ; Lammers T; Seevinck PR; Storm G; van Nostrum CF; Hennink WE
    Langmuir; 2009 Feb; 25(4):2060-7. PubMed ID: 19166276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles.
    Tiyaboonchai W; Limpeanchob N
    Int J Pharm; 2007 Feb; 329(1-2):142-9. PubMed ID: 17000065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-responsive magnetic particles for biomedical applications.
    Medeiros SF; Santos AM; Fessi H; Elaissari A
    Int J Pharm; 2011 Jan; 403(1-2):139-61. PubMed ID: 20951779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric nanoparticles for drug delivery.
    Chan JM; Valencia PM; Zhang L; Langer R; Farokhzad OC
    Methods Mol Biol; 2010; 624():163-75. PubMed ID: 20217595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation.
    Chambers E; Mitragotri S
    Exp Biol Med (Maywood); 2007 Jul; 232(7):958-66. PubMed ID: 17609513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
    Tomalia DA; Reyna LA; Svenson S
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):61-7. PubMed ID: 17233602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting toxicity and efficacy of polymeric nanomedicines.
    Igarashi E
    Toxicol Appl Pharmacol; 2008 May; 229(1):121-34. PubMed ID: 18355886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized functionalization of individual colloidal carriers for cell targeting and imaging.
    Yake AM; Zahr AS; Jerri HA; Pishko MV; Velegol D
    Biomacromolecules; 2007 Jun; 8(6):1958-65. PubMed ID: 17477569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of nanotechnology in biomedicine.
    Navalakhe RM; Nandedkar TD
    Indian J Exp Biol; 2007 Feb; 45(2):160-5. PubMed ID: 17375555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of nanoparticles: folate receptor.
    Kularatne SA; Low PS
    Methods Mol Biol; 2010; 624():249-65. PubMed ID: 20217601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
    Fadeel B; Garcia-Bennett AE
    Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles in medicine: therapeutic applications and developments.
    Zhang L; Gu FX; Chan JM; Wang AZ; Langer RS; Farokhzad OC
    Clin Pharmacol Ther; 2008 May; 83(5):761-9. PubMed ID: 17957183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.